2025 annual financial data
ImmunityBio, Inc. 2025 Operating margin
ImmunityBio, Inc. 2025 operating margin with verified reported values.
Direct answer
Operating margin was -226%.
Operating income was -256,027,000 USD and net income was -351,398,000 USD.
Operating cash flow was -304,936,000 USD.
Get free ImmunityBio, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 113,288,000 USD
- Operating income
- -256,027,000 USD
- Net income
- -351,398,000 USD
- Operating cash flow
- -304,936,000 USD